Synergies among the three businesses: tissue culture, microbiology and cell processing
First written in FY2024. 2 of 3 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「In addition to developing the three businesses of tissue culture, microbiology and cell processing, our greatest distinguishing feature and competitive advantage is that we use the synergies created by combining these businesses in our operations.」
The company continues to position the combination of the three businesses as a competitive advantage and is defining the scope of synergies more specifically, including the use of proprietary media in the cell processing business and the sharing of customer bases and sales networks with the microbiology business. - FY2025RestatedAnnual report
「We can use our proprietary cell culture media in the cell processing business, which enables us to keep the cost ratio of cell processing operations low and thereby increase profitability. In addition, using our own media in the cell processing business allows us to obtain rapid internal feedback on the media's performance, leading to improvements in product performance and quality.」
The company continues to explain the specific benefits of synergies among the three businesses, including lower costs through the use of proprietary media, performance feedback and quality improvements. - FY2024First statedAnnual report
「In addition to developing the three businesses of tissue culture, microbiology and cell processing, our greatest distinguishing feature and competitive advantage is that we use the synergies created by combining these businesses in our operations.」
The combination of the three businesses is positioned as a competitive advantage.